Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Forget Nasdaq. China’s biotechs with blockbuster IPO dreams are switching focus to Hong Kong
8 years ago
Financing
Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May
8 years ago
Financing
Endpoints' China coverage is getting deeper. Announcing our partnership with PharmCube, the leading Chinese biopharma data provider
8 years ago
Publisher's note
As gene editing explodes, a new report from Goldman says Chinese groups are seizing the lead on CRISPR and CAR-T studies
8 years ago
After a makeover and hiring spree, China's drug agency is romping and stomping on new reviews and approvals
8 years ago
Pharma
Chinese oncology startup Adagene closes $50M Series C led by Sequoia Capital
8 years ago
Financing
Startups
China's biotech pipeline is brimming with PD-1/L1 checkpoints. Are they really needed?
8 years ago
Shakeup at China FDA after chief vaults to the helm of a regulatory umbrella group, new agency head named
8 years ago
People
China stocks the new trend? Loncar launches index
8 years ago
Pharma
Bye CFDA: China's drug regulator to take new shape in major government restructuring
8 years ago
Hua Medicine plans to join trendy Hong Kong IPO club, pitching an offering of up to $400M -- reports
8 years ago
Financing
Juno, WuXi JV gets a $90M round as China’s CAR-T pioneers fly high with fresh cash
8 years ago
Financing
Oxford Vacmedix moves cancer vaccines forward with $12.5M from South Korea, China
8 years ago
Financing
Chinese medicine player Tasly considers Hong Kong IPO for its biotech arm: report
8 years ago
Financing
Novartis’ oncology research chief in China jumps to upstart EpimAb in Shanghai
8 years ago
People
A week of UK deals exemplifies China’s growing role in global biotech investment
8 years ago
Billion-dollar biosim maker mulls $500M Hong Kong IPO
8 years ago
Financing
After EMA flop, Puma takes Nerlynx to China in new out-licensing deal
8 years ago
Pharma
Fast-growing Shanghai Pharma to plant foot in San Diego, hunting deals in US and Europe
8 years ago
In a breakthrough, Chinese researchers clone monkeys hoping to provide better disease models
8 years ago
China's KBP Bio is coming to America, with $76M A round and GSK vet taking the helm in Philly
8 years ago
Financing
Pharma
Chinese dealmaking: SARI nabs Italy’s NMS Group for $362M; Inovio retools deal with ApolloBio
8 years ago
Pharma
Star drugs like BMS' Opdivo, AstraZeneca's Lynparza will get speedy OKs in China this year, new report predicts
8 years ago
Pharma
AstraZeneca teams with China-owned fund to launch a new biopharma drug development company
8 years ago
Financing
First page
Previous page
25
26
27
28
29
30
Next page
Last page